Abstract
Innate and adaptive immune system cells play a major role in regulating the growth of cancer. Although it is commonly thought that an immune response localized to the tumor will inhibit cancer growth, it is clear that some types of inflammation induced in a tumor may also lead to cancer proliferation, invasion, and dissemination. Recent evidence suggests, however, that some patients with cancer can mount an antitumor immune response that has the potential to control or eliminate cancer. Indeed, a so-called “immune response” signature has been described in malignancy that is associated with improved outcomes in several tumor types. Moreover, the presence of specific subsets of T cells, which have the capability to penetrate tumor stroma and infiltrate deep into the parenchyma, identifies patients with an improved prognosis. Immune-based therapies have the potential to modulate the tumor microenvironment by eliciting immune system cells that will initiate acute inflammation that leads to tissue destruction.
Keywords
Immune systemCancerInflammationMedicineTumor microenvironmentCancer researchCancer cellStromaAcquired immune systemImmunologyMalignancyImmunotherapyTumor progressionPathologyInternal medicineImmunohistochemistry
Affiliated Institutions
Related Publications
TIMER2.0 for analysis of tumor-infiltrating immune cells
Abstract Tumor progression and the efficacy of immunotherapy are strongly influenced by the composition and abundance of immune cells in the tumor microenvironment. Due to the l...
Understanding the tumor immune microenvironment (TIME) for effective therapy
The clinical successes in immunotherapy have been both astounding and at the same time unsatisfactory. Countless patients with varied tumor types have seen pronounced clinical r...
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Inflammatory conditions in selected organs increase the risk of cancer. An inflammatory component is present also in the microenvironment of tumors that are not epidemiologicall...
The biologic importance of tumor‐infiltrating lymphocytes
Detailed pathologic analysis has delineated a close association between intratumoral CD 8 + cytotoxic T cells and favorable clinical outcomes in diverse cancers. Conversely, the...
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Therapeutic antibodies that block the programmed death-1 (PD-1)–programmed death-ligand 1 (PD-L1) pathway can induce robust and durable responses in patients with various cancer...
Publication Info
- Year
- 2010
- Type
- article
- Volume
- 28
- Issue
- 29
- Pages
- 4531-4538
- Citations
- 480
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
480
OpenAlex
Cite This
Mary L. Disis
(2010).
Immune Regulation of Cancer.
Journal of Clinical Oncology
, 28
(29)
, 4531-4538.
https://doi.org/10.1200/jco.2009.27.2146
Identifiers
- DOI
- 10.1200/jco.2009.27.2146